In a recent published report, Kenneth Research has updated the market report for Blood Testing Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.
U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Blood Testing Market products.
Download Sample of This Strategic Report:- https://www.kennethresearch.com/sample-request-10070562
Kenneth Research has recently added a report titled Blood Testing Market in its storehouse of market research reports. The report provides a detailed insight into the market scenario on the basis of the market size and volume for the forecast period, i.e., 2021 2030. Factors such as the growing advancements in the development of novel drugs, coupled with the growing health infrastructure in several nations worldwide are anticipated to drive the growth of the market in the coming years. Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth.
According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018. Moreover, growing concern for deaths caused due to various diseases and the need for treatment that can lower the crude death rate, which in the year 2019 recorded close to 7% (per 1000 people), are also anticipated to drive the market growth during the forecast period.
The other key factors enhancing the global market growth include multiplying prevalence of infectious diseases such as bacterial and viral diseases and other health-related disorders such as HIV, cancer, thyroid, and genetic disorders, and the exponential increase in the number of point of care (POC) testing. Use of self-testing products and home diagnostic tests, blood testing in under-developed countries, and research and development for developing new testing technologies further provide growth opportunities for the blood testing market in the forecast period.
In the era of rapid and effective medical treatments, physicians and other medical personnel are dependent on various types of laboratory testing in order to make an accurate diagnosis and carry out subsequent treatment measures. Thus, increasing reliance on physicians for blood-based diagnosis to ensure reliable and rapid treatment procedures are the factors anticipated to enhance the blood testing market in the forecast period. Generally, the elderly population who are susceptible to age-related diseases such as diabetes and cardiovascular diseases require more frequent blood testing. Furthermore, the elderly population undergoes complex surgical procedures such as dialysis, joint replacements and cancer therapies which requires blood transfusions. These factors are anticipated to bolster the demand for blood testing in the upcoming years.
Recent times have witnessed an increase in the prevalence of infectious diseases such as bacterial and viral diseases, and other disorders such as HIV, cancer, thyroid, and genetic disorders in all age groups and population. Blood testing plays a vital role in the identification of the causative agents of these diseases and disorders thereby boosting the growth of this market. Also, the growing number of POC testing has led to the increased growth of the market.
Asia Pacific is anticipated to grow at the highest CAGR during the forecast period owing to the increasing economic growth in developing economies such as India, China and Japan. Various factors governing the growth in this region include large patient pool, increasing ageing population, rising standard of living, high disposable income, increasing health awareness, and improving medical facilities. Furthermore, global players are tapping into these countries, which in turn are expected to boost the market growth.
The different types of blood testing include glucose testing, lipid profile, liver function tests, prostate specific antigen, hormones, blood urea nitrogen, high-sensitivity c-reactive protein, thyroid stimulating hormone, serum nicotine/cotinine and others. The glucose testing segment is expected to dominate the market during the forecast period due to increasing population of diabetic patients and changing lifestyles. Blood glucose testing is conducted by both laboratories and point of care testing.
Request For full report-https://www.kennethresearch.com/sample-request-10070562
The major market players profiled in the report include Abbott Laboratories, Alere, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Beckman Coulter, bioMérieux SA, Biomerica Inc., Bruker Corporation, Nanosphere Inc., Nipro Diagnostics, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific Inc. and Trinity Biotech PLC among others. These market players have adopted various strategies such as merger & acquisitions, novel product development, and venture capital investments among others to expand their foothold and increase their customer base.
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation
Name: Kenneth research
Phone: +1 313 462 0609